Related Experiment Video
Updated: Aug 9, 2026

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions
Published on: April 23, 2021
Vascular cognitive impairment
Laura Pedelty1, David L Nyenhuis
1Section of Cognitive Disorders, Department of Neurology and Rehabilitation, University of Illinois College of Medicine at Chicago, 912 S. Wood Street, Room 855N, Chicago, IL 60612, USA. pedelty@uic.edu
Insights
Vascular cognitive impairment (VCI) presents as a spectrum of cognitive deficits due to cerebrovascular disease. Early risk factor management and recognizing executive function decline are key for prevention and treatment.
Area of Science:
- Neurology
- Gerontology
- Public Health
Background:
- Vascular cognitive impairment (VCI) is a spectrum of syndromes from mild impairment to dementia.
- Cerebrovascular pathology, including infarction and rarefaction, underlies VCI.
- Alzheimer's pathology can co-occur with vascular pathology.
Purpose of the Study:
- To define the spectrum of VCI.
- To outline diagnostic criteria and neuroimaging findings.
- To discuss therapeutic and preventive strategies.
Main Methods:
- Diagnosis relies on identifying cognitive impairment alongside documented cerebrovascular disease.
- Neuroimaging, particularly MRI, is crucial for diagnosis.
- Clinical presentation and course (stepwise or progressive) are assessed.
Main Results:
- VCI is characterized by executive function deficits, distinguishing it from Alzheimer's disease's memory impairment.
- MRI is more sensitive than CT for detecting underlying pathology.
- No specific VCI therapies exist, but some medications may offer symptomatic improvement.
Conclusions:
- Early recognition of at-risk populations and aggressive management of risk factors (hypertension, diabetes, dyslipidemia, smoking) are paramount for VCI prevention.
- Antithrombotic therapy may be beneficial in selected cases.
- Focus on risk factor modification is essential for managing VCI.
Abstract:
Vascular cognitive impairment encompasses a spectrum of clinically defined syndromes ranging from vascular cognitive impairment-no dementia, to vascular dementia. The underlying cerebrovascular pathology includes both overt infarction as well as rarefaction of gray and white matter. Alzheimer's pathology may coexist with vascular pathology. Diagnosis rests on identifying acquired cognitive impairment in the setting of documented cerebrovascular disease, based on clinical presentation and neuroimaging; MRI is more sensitive than CT. The course can be stepwise or gradually progressive. The clinical picture is typically dominated by deficits in executive function rather than the short-term memory deficit typical of Alzheimer's disease. No specific therapies exist, but treatment with anticholinesterase agents and N-methyl-d-aspartate antagonists may result in clinical improvement. Prevention remains paramount, with early recognition of populations at risk and early and aggressive management of risk factors, including hypertension, dyslipidemia, diabetes, and tobacco use as well as antithrombotic therapy, in appropriate populations.
Related Concept Videos
Dementia l: Introduction
Ischemic Stroke l: Introduction
Transient Ischemic Attack l: Introduction
Ischemic Stroke ll: Pathophysiology
Hemorrhagic Stroke ll: Pathophysiology
Hemorrhagic Stroke l: Introduction

